Wcg Wealth Advisors LLC Bristol Myers Squibb CO Transaction History

Wcg Wealth Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $47,020 - $53,312	980 Added 7.33%	14,356 $778,000
Q4 2023 Feb 08, 2024	SELL	$48.48 - $57.85 $18,373 - $21,925	-379 Reduced 2.76%	13,376 $686,000
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $747,359 - $835,664	-12,910 Reduced 48.42%	13,755 $887,000
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $11,595 - $12,874	182 Added 0.69%	26,665 $1.71 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $56,116 - $63,648	854 Added 3.33%	26,483 $1.84 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $64,919 - $76,873	948 Added 3.84%	25,629 $1.84 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $327 - $193,483	2,518 Added 11.36%	24,681 $1.76 Million
Q2 2022 Aug 23, 2022	BUY	$72.62 - $79.98 $1.61 Million - $1.77 Million	22,163 New	22,163 $1.71 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Wcg Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Wcg Wealth Advisors LLC with notifications on news.